About Company
- Legal Name: AqVida GmbH
- Registered country: Germany
- Address: Kaiser-Wilhelm-Str. 89, Hamburg
- Number of employees: 50 - 99
Description:
A German pharmaceutical company specializing in the development and production of oncology products, offering a range of oncology products with a continual focus on improving formulation and presentation for ease of handling, convenience and patient compliance. Its Generics+ products are produced at an innovative robotic manufacturing site in Germany.
Business Activities
Finished Dosage Forms
ManufacturerDistributor
Key Products/Services
- Finished Dosage Forms: Imatinib AqVida hard capsules*, Sunitinib AqVida hard capsules*, Docetaxel AqVida 20 mg/ml concentrate for solution for infusion, Epirubicin AqVida 2 mg/ml solution for injection, Irinotecan AqVida 20 mg/ml concentrate for solution for infusion, Oxaliplatin AqVida 5 mg/ml concentrate for solution for infusion, Paclitaxel AqVida 6 mg/ml concentrate for solution for infusion, Azacitidin AqVida 25 mg/ml concentrate for solution for infusion, Cabazitaxel AqVida 20 mg/ml concentrate for solution for infusion*, Gemcitabine AqVida 38 mg/ml powder for solution for infusion, Azathioprine AqVida film-coated tablets
Our Products & Services
Certifications
GMP
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment